Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Molecular Cancer Therapeutics|May 10, 2013
NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinomaRoshan J Thapa, Peirong Chen, Mitchell Cheung, et al.
Cancer Genetics|September 14, 2015
An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutationMitchell Cheung, Yuwaraj Kadariya, Jianming Pei, et al.
Cancer Genetics|April 8, 2014
Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphomaJianming Pei, Valentin Robu, Madelyn Feder, et al.
Cancer Research|October 7, 2004
Deregulated Akt3 activity promotes development of malignant melanomaJill M Stahl, Arati Sharma, Mitchell Cheung, et al.
Cancer Research|January 1, 2016
Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of CancerJill A Ohar, Mitchell Cheung, Jacqueline Talarchek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer modelSeiji Mabuchi, Deborah A Altomare, Mitchell Cheung, et al.
Cancer Research|February 21, 2016
Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 MutationsYuwaraj Kadariya, Mitchell Cheung, Jinfei Xu, et al.
Pageof 3